ATA Thyroid Cancer

Articles

Memorial Sloan Kettering Cancer Center’s experience shows that selected patients with low-risk papillary thyroid cancer can safely defer surgery in favor of active surveillance.

MSKCC Implementation of Active Surveillance for Thyroid Cancer

In this interview we discuss which distant metastases in thyroid cancer are appropriate targets for I-131 treatment, appropriate dosing, and more.

I-131 for Thyroid Cancer Metastases

Dual inhibition of PI3K signaling and histone deacetylase 2 (HDAC2) enzymes with CUDC-907 slowed thyroid tumor cell proliferation, tumor progression and metastasis, according to a preclinical study.

PI3K, HDAC Inhibition With CUDC-907 Shows Promise in Thyroid Cancer

Mitochondrial glycerophosphate dehydrogenase (mGPDH) is overexpressed in differentiated thyroid cancer (DTC) tissue, and metformin, which downregulates mGPDH, is associated with slowed growth in metastatic DTC tumors in mice.

Metformin Delays Progression of Thyroid Tumor Metastases in Mice

The risk of immunotherapy-related destructive thyroiditis requires close patient monitoring and can cause permanent hypothyroidism.

Immunotherapy Patients Should Be Monitored for Destructive Thyroiditis

Five years after treatment, low-dose postsurgical radioiodine (I-131) ablation for low-risk thyroid cancer offers outcomes equivalent to those seen following higher-dose ablation, according to a long-term follow-up analysis by French researchers.

Long-Term Data Validate Low-Dose I-131 for Low-Risk Thyroid Cancer

As part of our coverage of the 2016 American Thyroid Association Annual Meeting we discuss active surveillance vs immediate lobectomy or thyroidectomy in papillary thyroid microcarcinoma.

Papillary Thyroid Microcarcinoma: Surveillance or Immediate Biopsy, Surgery? 

A MALDI-TOF mass spectrometry (MassARRAY) mutation-detection panel shows promise for improving the presurgical diagnosis of thyroid cancers with fine needle aspirations, according to a pilot study.

MassARRAY Mutation-Detection Panel Improves Presurgical Thyroid Cancer Diagnosis

In this interview on medullary thyroid carcinoma we discuss treatment strategies, prognostic biomarkers, surveillance following treatment, and more.

Clinical Management of Medullary Thyroid Carcinoma

High-risk ultrasound findings strongly indicate that thyroid nodules are malignant, even when nodules are cytologically indeterminate following find needle aspiration.

ATA Thyroid Cancer | Conference